APELOA: The Phase III clinical trial of the Semaglutide project has completed all enrollments
APELOA stated on the interactive platform that the Phase III clinical trial for its semaglutide project (including indications for weight loss and blood sugar reduction) has completed all patient enrollment and is currently in the follow-up phase of administration
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments